Akers Biosciences, Inc., a medical device company focused on reducing the cost of healthcare through faster, easier diagnostics, introduced two new breath tests to the U.S. market from the Company's Akers Wellness division at the World Congress on Anti-Aging Medicine in Hollywood, Florida, USA last week.

BreathScan(R) OxiChek(TM) ("OxiChek(TM)") and BreathScan(R) KetoChek(TM) ("KetoChek(TM)"), together with the Bluetooth(R)-enabled reading device, BreathScan Lync(TM) - which synchs via an app on any mobile device - will enable users to monitor trends in critical metabolic processes. The products will provide healthcare professionals, suppliers of nutritional supplements and weight loss plans, as well as health coaches, the ability to more effectively demonstrate, monitor and adjust the efficacy of their products and the progress of their clients. These products may also provide such customers with an opportunity for significant revenue enhancement through distribution for in-office and at-home use of the devices.

OxiChek(TM) is the first disposable breath test to rapidly determine levels of oxidative stress (free radicals) in the body. OxiChek(TM) measures the most abundant free radicals, including superoxides, hydrogen peroxide and aldehydes - unlike some pre-existing devices which measure only one. Frequent use of OxiChek(TM) may help users comply with and adhere to their regimen of nutritional supplementation for management of oxidative stress, which is implicated in many diseases including cardiac, cancer and arthritic diseases.

KetoChek(TM) is a second generation enhancement of the Company's METRON(R) breath ketone test. KetoChek(TM), to our knowledge, is the only disposable breath-based diagnostic device that provides rapid, quantitative assessment of the presence of ketones, to determine if the subject is in the optimal fat-burning state for weight loss, known as ketosis. Achieving a state of ketosis is a goal of many individuals following low carbohydrate, ketogenic diets. KetoChek(TM) is a simple, non-invasive test to track and monitor for ketosis in individuals interested in maximizing weight loss, as well as endurance athletes wanting to activate fat-burning metabolism.

The innovative BreathScan Lync(TM) device works with both OxiChek(TM) and KetoChek(TM), to display and track results over time via Bluetooth(R), to any iOS (Apple) or Android mobile device.

"We believe that personalized health information is the wave of the future and that this suite of BreathScan products, including OxiChek(TM), KetoChek(TM) and the BreathScan Lync(TM), will provide tremendous value to healthcare professionals, consumers, and diet and supplement manufacturers within the health and wellness industry," said Raymond F. Akers, Jr. PhD, Co-founder and Executive Chairman.

"Our KetoChek(TM) test can help individuals achieve ketosis, which is a state of optimal fat burning, while OxiChek(TM) can help them better optimize lifestyle and supplement utilization to control free radical levels. Since higher free radical levels have been shown to correlate with age, OxiChek(TM) is providing important information that can greatly enhance an individual's ability to take control of their aging process," continued Dr. Akers.

"Health and wellness is a trillion dollar business globally and our proprietary technology for testing breath condensate is a highly effective diagnostic tool for professionals and consumers in this industry. Whether in health and wellness or medical diagnostics, our faster, easier diagnostic tests provide information that make lives better," added Dr. Akers.

The Company is in discussions with a number of strategic partners specializing in the health and wellness industry with regards to the commercialization of OxiChek(TM), KetoChek(TM), and BreathScan Lync(TM).